Dividends Calendar Earnings Calendar
CBAY

CBAY | Cymabay Therapeutics Inc

Cymabay Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Newark, California, United States

Trade prices

  • Volume:
  • Market Cap: 170.2M
  • Prev closed:
  • Open: 3.04
  • High: 3.2
  • Low: 3.04
  • 52 week low: 2.67
  • 52 week high: 5.13
  • Dividends:No Dividends

Next ER: May 12, 2022  After Market Closes



Top Stories (CBAY)

    Company Profile

    We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. We are evaluating seladelpar in primary biliary cholangitis (PBC). We also have a product program in earlier development that features a unique mechanism of action with potential in chronic diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 11, 2022
    May 12, 2022-0.32 / -0.3125- / -
    March 17, 2022-0.34 / -0.2613- / 6.43M
    November 10, 2021-0.33 / -0.2633- / -
    August 12, 2021-0.34 / -0.2678- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jun 24, 2022 2.820 2.610
    2.820
    2.330
    10.38M 8.88%
    Jun 23, 2022 2.590 2.380
    2.590
    2.310
    787.33K 7.92%
    Jun 22, 2022 2.400 2.070
    2.446
    2.030
    1.11M 16.50%
    Jun 21, 2022 2.060 1.990
    2.110
    1.990
    631.97K 4.57%
    Jun 17, 2022 1.970 1.910
    2.040
    1.880
    756.54K 3.14%
    Jun 16, 2022 1.910 1.910
    1.920
    1.810
    634.93K -1.04%
    Jun 15, 2022 1.930 2.050
    2.090
    1.850
    742.82K -3.98%
    Jun 14, 2022 2.010 2.130
    2.180
    2.000
    506.25K -5.19%
    Jun 13, 2022 2.120 2.160
    2.160
    2.030
    595.05K -5.78%
    Jun 10, 2022 2.250 2.350
    2.410
    2.190
    606.97K -6.64%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1988
    • Employees:59

    News

    News for (CBAY)

    This company doesn't provide a dividend.


    Talk about Cymabay Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 12, 2022 (Same day)

    newr msi tef cybr agro crbp iii acb fwona we codx usfd 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    TwitterFacebookLinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!